Fractl looked into online OTC birth control searches for HBW Insight after initially focusing on interest in male birth control options since the Supreme Court’s ruling in Dobbs vs. Jackson.
Approval is high among US voters for making birth control pills available OTC, and the number of consumers already looking for the option is climbing rapidly.
Power Life Sciences Inc., which provides platform linking consumers to clinical trial opportunities, gauged interest in male birth control options...
Norway becomes the third European country to approve OTC sales of tadalafil. Cialis reseptfri will “soon be on shelves,” Opella says, with the launched being planned in partnership with Stada Arzneimittel.
Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.
Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.
Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.
Haleon adds herbal pain relief to Voltaren topicals line, Bayer launches herbal expectorant in time for autumn and Angelini creates a throat spray that meets German Society for General Practice and Family Medicine guidelines.
Brent Wisner suggests FDA “should be focusing on slowing down and making sure they get it right. Because at the end of the day, getting it right is more important than making sure drug companies can make more money. That shouldn't be the priority.”
Stada is set for new ownership after CapVest agreed to buy a controlling stake from Bain Capital and Cinven. CapVest is pledging to “deploy significant new capital” to advance Stada’s interests, with the German giant’s CEO hinting at “ambitious plans” for the future.
